ArticlePloS one2023

A novel drug specific mRNA biomarker predictor for selection of patients responding to dovitinib treatment of advanced renal cell carcinoma and other solid tumors.

Steen Knudsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.